From: Economic burden of beta-thalassemia/Hb E and beta-thalassemia major in Thai children
Outpatient | Hospitalization | Average length of stay (days, SD) | Blood | |||
---|---|---|---|---|---|---|
Category | service (visits, SD) | (%) | Per all patients | Per hospitalized patients | transfusion (times, SD) | Desferrioxamine (vials, SD) |
Hospital | ||||||
Saraburi (N = 72) | 6.74 (3.31) | 15 (20.8%) | 0.68 (1.76) | 3.27 (2.58) | 3.69 (3.59) | 3.43 (20.42) |
Phramongkutklao (N = 42) | 9.76 (4.44) | - | - | - | 8.64 (5.74) | 93.95 (105.41) |
Chulalongkorn (N = 87) | 11.05 (4.37) | 7 (8.0%) | 0.69 (3.48) | 8.57 (9.74) | 9.86 (5.44) | 53.77 (82.50) |
Disease type | ||||||
Beta-thal/Hb E (N = 183) | 8.86 (4.31) | 20 (10.9%) | 0.57 (2.64) | 5.25 (6.39) | 6.94 (5.57) | 39.59 (79.17) |
Homozygous beta-thal (N = 18) | 13.06 (4.30) | 2 (11.1%) | 0.22 (0.73) | 2.00 (1.41) | 12.06 (4.32) | 90.33 (83.78) |
Severity | ||||||
Severe (N = 94) | 10.41 (4.14) | 16 (17.0%) | 0.95 (3.53) | 5.56 (7.07) | 9.35 (4.93) | 58.63 (89.75) |
Nonsevere (N = 106) | 8.26 (4.46) | 6 (5.7%) | 0.19 (0.92) | 3.33 (2.25) | 5.74 (5.72) | 31.70 (70.03) |
Ferritin level | ||||||
≤ 2,500 ng/ml (N = 77) | 10.60 (3.51) | 5 (6.5%) | 0.17 (0.80) | 2.60 (2.07) | 8.96 (4.55) | 51.38 (88.92) |
> 2,500 ng/ml (N = 50) | 11.76 (3.91) | 5 (10.0%) | 1.20 (4.60) | 12.00 (9.82) | 11.24 (4.94) | 96.02 (92.76) |
Complications | ||||||
Yes (N = 18) | 11.83 (3.92) | 3 (16.7%) | 0.56 (1.54) | 3.33 (2.52) | 10.39 (4.84) | 113.44 (123.39) |
No (N = 183) | 8.98 (4.44) | 19 (10.4%) | 0.54 (2.61) | 5.21 (6.56) | 7.10 (5.65) | 37.32 (72.18) |
Total | 201 | 22 (10.9%) | 201 | 22 | 201 | 201 |
Mean | 9.23 | n/a | 0.54 | 4.95 | 7.40 | 44.13 |
Standard deviation (SD) | 4.46 | n/a | 2.53 | 6.16 | 5.65 | 80.69 |
Median | 9.00 | n/a | 0.00 | 3.00 | 8.00 | 0.00 |
95% CI | ||||||
Lower | 8.61 | n/a | 0.19 | 2.22 | 6.61 | 32.91 |
Upper | 9.85 | n/a | 0.89 | 7.69 | 8.18 | 55.36 |